Hillsdale Investment Management Inc. Organon & Co. Transaction History
Hillsdale Investment Management Inc.
- $1.21 Billion
- Q3 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Organon & Co. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 34,750 shares of OGN stock, worth $508,045. This represents 0.06% of its overall portfolio holdings.
Number of Shares
34,750Holding current value
$508,045% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding OGN
# of Institutions
793Shares Held
204MCall Options Held
1.71MPut Options Held
870K-
Black Rock Inc. New York, NY32.6MShares$476 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$441 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.2MShares$163 Million0.41% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$143 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$131 Million0.01% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $3.72B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...